Teladoc Health, Inc.
TDOC- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001477449
In the last 90 days, Teladoc Health, Inc. insiders filed 0 open-market purchases and 9 sales; 347 institutions reported holding it in 13F filings for Q2 2026, worth $1.29B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Teladoc Health, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 356
- −1 vs. Q2 2025
- Shares held
- 123.5M
- −4.15M (−3.3%) vs. Q2 2025
- Total value
- $954.5M
- −$157.9M (−14.2%) vs. Q2 2025
- New holders
- 55
- 116 more added
- Sold out
- 56
- 100 more reduced
3 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TDOC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 347 | $1.29B |
| Q1 2026 | 325 | $776.7M |
| Q4 2025 | 344 | $926.5M |
| Q3 2025 | 356 | $954.5M |
| Q2 2025 | 360 | $1.11B |
| Q1 2025 | 385 | $998.5M |
| Q4 2024 | 382 | $1.15B |
| Q3 2024 | 367 | $1.15B |
| Q2 2024 | 407 | $1.36B |
| Q1 2024 | 427 | $1.97B |
| Q4 2023 | 436 | $2.77B |
| Q3 2023 | 438 | $2.33B |
| Q2 2023 | 432 | $3.27B |
| Q1 2023 | 431 | $3.54B |
| Q4 2022 | 446 | $3.19B |
| Q3 2022 | 483 | $3.51B |
| Q2 2022 | 552 | $4.76B |
| Q1 2022 | 681 | $10.0B |
| Q4 2021 | 729 | $13.0B |
| Q3 2021 | 764 | $17.0B |
| Q2 2021 | 831 | $21.3B |
| Q1 2021 | 892 | $22.1B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Teladoc Health, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kozak & Associates, Inc. | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Curio Wealth, LLC | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Archer Investment Corp | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Raleigh Capital Management Inc. | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Transce3nd, LLC | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Financial Management Professionals, Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Garde Capital, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| JFS Wealth Advisors, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Wood Tarver Financial Group, LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| Norges Bank | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| First Horizon Advisors, Inc. | – | – | – | – | Not filed |